International Stem Cell Corporation

ISCO · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$209-$131-$331-$899
Dep. & Amort.$206$194$218$262
Deferred Tax$0$0$0-$887
Stock-Based Comp.$466$464$399$644
Change in WC-$809$100-$227-$823
Other Non-Cash$359$302$273$406
Operating Cash Flow$13$929$332-$1,297
Investing Activities
PP&E Inv.-$166-$80-$11-$45
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$5-$3-$10-$22
Investing Cash Flow-$171-$83-$11-$45
Financing Activities
Debt Repay.-$200$0$250$824
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$200$0$250$824
Forex Effect$0$0$0$0
Net Chg. in Cash-$358$846$571-$518
Supplemental Information
Beg. Cash$1,588$742$171$689
End Cash$1,230$1,588$742$171
Free Cash Flow-$153$846$321-$1,342